Therapeutic Potential of Apigenin, a Plant Flavonoid, for Imatinib-Sensitive and Resistant Chronic Myeloid Leukemia Cells

REFERENCES

• Quinta's-Cardama A, and Cortes JE: Molecular biology of bcr-abl1–positive chronic myeloid leukemia. Blood 113, 1619–1630, 2009.
   PubMed Web of Science ®Google Scholar
• Faderl S, Talpaz M, Estrov Z, O’Brien S, Kurzrock R, et al.: The biology of chronic myeloid leukemia. N Engl J Med 341, 164–172, 1999.
   PubMed Web of Science ®Google Scholar
• Di Bacco A, Keeshan K, McKenna SL, and Cotter TG: Molecular abnormalities in chronic myeloid leukemia: deregulation of cell growth and apoptosis. Oncologist 5, 405–415, 2000.
   PubMedGoogle Scholar
• Frazer R, Irvine AE, and McMullin MF: Chronic myeloid leukaemia in the 21st century. Ulster Med J 76, 8–17, 2007.
   PubMedGoogle Scholar
• Hurtado R, Vargas P, and Cortes J: Chronic myeloid leukemia current concepts in physiopathology and treatment. T Cancerologia 2, 137–147, 2007.
   Google Scholar
• Quintás-Cardama A, Kantarjian HM, and Cortes JE: Mechanisms of primary and secondary resistance to imatinib in chronic myeloid leukemia. Cancer Control 16, 122–131, 2009.
   PubMed Web of Science ®Google Scholar
• Ramirez P and DiPersio JF : Therapy options in imatinib failures. Oncologist 13, 424–434, 2008.
   PubMed Web of Science ®Google Scholar
• Melo JV and Chuah C: Novel agents in CML therapy: tyrosine kinase inhibitors and beyond. Hematology Am Soc Hematol Educ Program 2008, 427–435, 2008.
   Google Scholar
• Santos FP and Ravandi F: Advances in treatment of chronic myelogenous leukemia new treatment options with tyrosine kinase inhibitors. Leuk Lymphoma 2, 16–26, 2009.
   Web of Science ®Google Scholar
• Monasterio A, Urdaci MC, Pinchuk IV, Lopez-Moratalla N, and Martinez-Irujo JJ: Flavonoids induce apoptosis in human leukemia U937 cells through caspase- and caspase-calpain–dependent pathways. Nutrition and Cancer 50, 90–100, 2004.
   PubMed Web of Science ®Google Scholar
• Patel D, Shukla S, and Gupta S: Apigenin and cancer chemoprevention: Progress, potential and promise. International Journal of Oncology 30, 233–245, 2007.
   PubMed Web of Science ®Google Scholar
• Shukla S and Gupta S: Apigenin: A promising molecule for cancer prevention. Pharm Res 27, 962–978, 2010.
   PubMed Web of Science ®Google Scholar
• Ruela-de-Sousa RR, Fuhler GM, Blom N, Ferreira CV, Aoyama H, et al.: Cytotoxicity of Apigenin on leukemia cell lines: implications for prevention and therapy. Cell Death Dis 1, 1–19, 2010.
   Web of Science ®Google Scholar
• Chan LP, Chou TH, Ding HY, Chen PR, Chiang FY, et al.: Apigenin induces apoptosis via tumor necrosis factor receptor- and Bcl-2-mediated pathway and enhances susceptibility of head and neck squamous cell carcinoma to 5-fluorouracil and cisplatin. Biochimica et Biophysica Acta 1820, 1081–1091, 2012.
   PubMed Web of Science ®Google Scholar
• Iwasaki R, Ito K, Ishida T, Hamanoue M, Adachi S, et al.: Catechin, green tea component, causes caspase-independent necrosis-like cell death in chronic myelogenous leukemia. Cancer Sci 100, 349–356, 2009.
   PubMed Web of Science ®Google Scholar
• Vargo MA, Voss OH, Poustka F, Cardounel AJ, Grotewold E, et al.: Apigenin-induced-apoptosis is mediated by the activation of PKCdelta and caspases in leukemia cells. Biochem Pharmacol 72, 681–692, 2006.
   PubMed Web of Science ®Google Scholar
• Lu HF, Chie YJ, Yang MS, Lee CS, Fu JJ, et al.: Apigenin induces caspase-dependent apoptosis in human lung cancer A549 cells through Bax- and Bcl-2-triggered mitochondrial pathway. Int J Oncol 36, 1477–1484, 2010.
   PubMed Web of Science ®Google Scholar
• Choi EJ and Kim GH: Apigenin induces apoptosis through a mitochondria/caspase-pathway in human breast cancer MDA-MB-453 cells. J Clin Biochem Nutr 44, 260–265, 2009.
   PubMed Web of Science ®Google Scholar
• Wang IK, Lin-Shiau SY, and Lin JK: Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaemia HL-60 cells. Eur J Cancer 35, 1517–1525, 1999.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Mejia ME, Voss OH, Murnan EJ, and Doseff AI: Apigenin-induced apoptosis of leukemia cells is mediated by a bimodal and differentially regulated residue-specific phosphorylation of heat-shock protein-27. Cell Death Dis 1, e64, 2010.
   PubMed Web of Science ®Google Scholar
• Salas A, Ponnusamy S, Senkal CE, Meyers MA, Selvam SP, et al.: Sphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate Bcr-Abl1 stability and drug resistance by modulation of protein phosphatase 2A. Blood 117, 5941–5952, 2011.
   PubMed Web of Science ®Google Scholar
• Baran Y, Bielawski J, Ogretmen B, and Gunduz U: Inhibition of glucosylceramide synthase by PDMP resensitizes multidrug-resistant human chronic myeloid leukemia cells to ımatinib. Journal of Cancer Research and Clinical Oncology 137, 1535–1544, 2011.
   PubMed Web of Science ®Google Scholar
• Avcı CB, Gunduz C, Baran Y, Sahin F, Yilmaz S, et al.: Caffeic acid phenethyl esther triggers apoptosis through ınduction of loss of mitochondrial membrane potential in CCRF-CEM. Journal of Cancer Research and Clinical Oncology 137, 41–47, 2011.
   PubMed Web of Science ®Google Scholar
• Chen D, Daniel KG, Chen MS, Kuhn DJ, Landis-Piwowar KR, et al.: Dietary flavonoids as proteasome inhibitors and apoptosis inducers in human leukemia cells. Biochem Pharmacol 69, 1421–1432, 2005.
   PubMed Web of Science ®Google Scholar
• Wang W, Heideman L, Chung CS, Pelling JC, Koehler KJ, et al.: Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines. Mol Carcinog 28, 102–110, 2000.
   PubMed Web of Science ®Google Scholar
• Shukla S and Gupta S: Apigenin-induced cell cycle arrest is mediated by modulation of MAPK, PI3K-Akt, and loss of cyclin D1 associated retinoblastoma dephosphorylation in human prostate cancer cells. Cell Cycle 6, 1102–1114, 2007.
   PubMed Web of Science ®Google Scholar
• Arakawa H: Netrin-1 and its receptors in tumorigenesis. Nat Ev Cancer 4, 978–987, 2004.
   PubMed Web of Science ®Google Scholar
• Thiebault K, Mazelin L, Pays L, Llambi F, Joly MO, et al.: The netrin-1 receptors UNC5H are putative tumor suppressors controlling cell death commitment. Proc Natl Acad Sci USA 100, 4173–4178, 2003.
   PubMed Web of Science ®Google Scholar
• Miyamoto Y, Futamura M, Kitamura N, Nakamura Y, Baba H, et al.: Identification of UNC5A as a novel transcriptional target of tumor suppressor p53 and a regulator of apoptosis. Int J Oncol. 36, 1253–1260, 2010.
   PubMed Web of Science ®Google Scholar
• Huang J, Zheng DL, Qin FS, Cheng N, Chen H, et al.: Genetic and epigenetic silencing of SCARA5 may contribute to human hepatocellular carcinoma by activating FAK signaling. J Clin Invest 120, 223–241, 2010.
   PubMed Web of Science ®Google Scholar
• Tonks A, Pearn L, Musson M, Gilkes A, Mills KI, et al.: Transcriptional dysregulation mediated by RUNX1-RUNX1T1 in normal human progenitor cells and in acute myeloid leukaemia. Leukemia 21, 2495–2505, 2007.
   PubMed Web of Science ®Google Scholar
• Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, et al.: miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A 102, 13944–13949, 2005.
   PubMed Web of Science ®Google Scholar
• Katoh M and Katoh M: Identification and characterization of human SNAIL3 (SNAI3) gene in silico. Int J Mol Med 11, 383–388, 2003.
   PubMed Web of Science ®Google Scholar
• Tsuruo T, Naito M, Tomida A, Fujita N, Mashima T, et al.: Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal. Cancer Sc. 294, 15–21, 2003.
   Web of Science ®Google Scholar
• Chen J, Petrus M, Bamford R, Shih JH, Morris JC, et al.: Increased serum soluble IL-15Rα levels in T-cell large granular lymphocyte leukemia. Blood 119, 137–143, 2012.
   PubMed Web of Science ®Google Scholar
• Loos M, Künzli B, and Friess H: Quantitation of CD39 gene expression in pancreatic tissue by real-time polymerase chain reaction. Methods Mol Biol 576, 351–362, 2010.
   PubMedGoogle Scholar
• Baldanzi G, Pietronave S, Locarno D, Merlin S, Porporato P, et al.: Diacylglycerol kinases are essential for hepatocyte growth factor-dependent proliferation and motility of Kaposi's sarcoma cells. Cancer Sci 10, 1329–1336, 2011.
   Web of Science ®Google Scholar
• Plasschaert SL, de Bont ES, Boezen M, vander Kolk DM, Daenen SM, et al.: Expression of multidrug resistance-associated proteins predicts prognosis in childhood and adult acute lymphoblastic leukemia. Clin Cancer Res 11, 8661–8668, 2005.
   PubMed Web of Science ®Google Scholar
• Sohail A, Sun Q, Zhao H, Bernardo MM, Cho JA, et al.: MT4-(MMP17) and MT6-MMP (MMP25), A unique set of membrane-anchored matrix metalloproteinases: properties and expression in cancer. Cancer Metastasis Rev 27, 289–302, 2008.
   PubMed Web of Science ®Google Scholar